CVALF (Covalon Technologies) Total Current Liabilities: $2.71 Mil (As of Mar. 2026)


CVALF Covalon Technologies Ltd CVALF
82 GF Score
Price $1.56
GF Value $1.54
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Covalon Technologies Total Current Liabilities?

Covalon Technologies CVALF -0.64% 82 Total Current Liabilities is $2.71 Mil as of Mar. 2026. GuruFocus rates CVALF with a GF Score™ of 82/100 and a GF Value™ of $1.54 (Fairly Valued). The stock has 2 warning signs investors should review.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Covalon Technologies's total current liabilities for the quarter that ended in Mar. 2026 was $2.71

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Covalon Technologies Total Current Liabilities Related Terms

Covalon Technologies Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for Covalon Technologies's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Covalon Technologies Total Current Liabilities Chart

Covalon Technologies Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.94 3.40 3.84 2.95 2.73

Covalon Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.71 3.53 2.73 3.53 2.71
CVALF
82GF Score
Covalon Technologies Ltd CVALF
Total Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Covalon Technologies Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Covalon Technologies's Total Current Liabilities for the fiscal year that ended in Sep. 2025 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=2.272+0.453
+Other Current Liabilities+Current Deferred Liabilities
=4.4408920985006E-16+0
=2.73

Covalon Technologies's Total Current Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=2.39+0.242
+Other Current Liabilities+Current Deferred Liabilities
=0+0.08
=2.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of $2.71 Mil mean?
Covalon Technologies (CVALF) has a Total Current Liabilities of $2.71 Mil as of Mar. 2026. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Covalon Technologies and its competitors.
Is Covalon Technologies' Total Current Liabilities too high?
Covalon Technologies' current Total Current Liabilities is $2.71 Mil. Overall, Covalon Technologies has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Covalon Technologies' Total Current Liabilities compare to ISRG and BDX?
Covalon Technologies' Total Current Liabilities of $2.71 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Medical Devices & Instruments company?
A good Total Current Liabilities depends on the Medical Devices & Instruments industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Covalon Technologies and its competitors. Covalon Technologies's current Total Current Liabilities is $2.71 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Covalon Technologies stock overvalued right now?
Based on GuruFocus' analysis, Covalon Technologies (CVALF) is currently considered Fairly Valued. The stock's GF Value™ is $1.54, compared to a current price of $1.56 — trading 1.3% above its estimated fair value. The current Total Current Liabilities is $2.71 Mil. Covalon Technologies' overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For Covalon Technologies (CVALF), the current Total Current Liabilities is $2.71 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Covalon Technologies (CVALF) Overvalued in 2026?

Based on GuruFocus' analysis, Covalon Technologies stock appears to be overvalued. The current stock price of $1.56 is trading 1.3% above its estimated GF Value™ of $1.54. GuruFocus considers Covalon Technologies to be Fairly Valued.

Key valuation signals for CVALF:

  • Total Current Liabilities: $2.71 Mil
  • GF Value™: $1.54 vs. price of $1.56 (1.3% above fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the CVALF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Covalon Technologies Business Description

Other Exchanges COV:Canada
Address 1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes in the areas of infection management, wound care, and surgical procedures. The company generates revenue through development contracts, licensing agreements, distribution contracts, and sales. Its products include IV dressings, surgical site protection products, vascular access protection products, and others, and its solutions include primary dressing cover, vascular access technologies, advanced wound care, sensitive skin solutions, custom medical coatings, and patient resource support.
82GF Score

Get the complete analysis for CVALF

Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.56
Price
$1.54
GF Value